Having trouble viewing this email? Click here to view in your web browser.
Adare Pharmaceuticals
Explore how Adare Pharmaceuticals addresses the unmet needs of patients
CPhIjapan 2016 Dear [insert recipient]:

We hope your spirits are high as the first signs of spring are right around the corner.

At Adare Pharmaceuticals, our capabilities allow our partners to differentiate their products early in development or throughout life-cycle management. This approach helps achieve desired target product profiles and may help address the needs of specific patient populations, such as pediatric and geriatric patients. Additionally, valuable patents can potentially be filed to extend exclusivity.

Our proprietary technologies can help meet patients’ needs by improving taste, promoting ease of administration, and adding convenience and safety—which may provide new uses for oral drug formulations.
White Paper
Adare also has a diverse portfolio of products available for out-licensing that use our proprietary drug delivery technologies. We’ve created these formulations with proven patient-centric benefits. Since 2009, our partnerships have resulted in over 60 product launches in 44 countries, including Japan and other Asian markets.

To learn more about our capabilities, download our pamphlet in your language:

Japanese Chinese Korean

We believe that Adare has something unique to offer you. We provide state-of-the-art formulation technology and capabilities, and we have experience with the quality standards and regulatory requirements of Asian markets. You can learn more about Adare here.

We look forward to the opportunity to meet with you and discuss how Adare Pharmaceuticals can serve your business needs. If you cannot attend this meeting, please contact [email protected] for more information.

Sincerely,

Dr Holger Neecke
Director
Business Development
Adare Pharmaceuticals Adare Pharmaceuticals
          ©2016 Adare Pharmaceuticals, Inc.
Adare Pharmaceuticals
         [Sender to insert opt-out language]